摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

diamantane-1,4-diol | 77076-31-4

中文名称
——
中文别名
——
英文名称
diamantane-1,4-diol
英文别名
Pentacyclo[7.3.1.14,12.02,7.06,11]tetradecane-1,4-diol
diamantane-1,4-diol化学式
CAS
77076-31-4
化学式
C14H20O2
mdl
——
分子量
220.312
InChiKey
VUFMDHVJBQUMQW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    16
  • 可旋转键数:
    0
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    40.5
  • 氢给体数:
    2
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    1-nitroxydiamantane硝酸 作用下, 生成 diamantane-1,4-diol
    参考文献:
    名称:
    硝酸介质中二金刚烷衍生物的合成
    摘要:
    摘要 通过使金刚烷与硝酸或HNO 3 -AcOH混合物反应,然后添加含氮亲核试剂,可以合成1-单-和1,4-双官能金刚烷衍生物。由2-金刚烷-1-醇和硫氰酸甲酯在硫酸中合成了N-(二金刚烷-1-基)氨基甲磺酸甲酯。
    DOI:
    10.1134/s1070428021020081
点击查看最新优质反应信息

文献信息

  • Hydroxy Derivatives of Diamantane, Triamantane, and [121]Tetramantane: Selective Preparation of Bis-Apical Derivatives
    作者:Natalie A. Fokina、Boryslav A. Tkachenko、Anika Merz、Michael Serafin、Jeremy E. P. Dahl、Robert M. K. Carlson、Andrey A. Fokin、Peter R. Schreiner
    DOI:10.1002/ejoc.200700378
    日期:2007.10
    Functionalizations of diamantane, triamantane, and tetramantane with electrophilic reagents (Br2, nitric acid) lead to various apical and medial disubstituted products that were separated and characterized individually. The highly desirable and otherwise inaccessible thermodynamically more stable apical bis-derivatives were obtained with high preparative yields through acid catalyzed isomerizations
    使用亲电试剂(Br2、硝酸)对金刚烷三金刚烷和四金刚烷进行官能化会产生各种顶端和中间双取代产物,这些产物被单独分离和表征。通过酸催化异构化以高制备产率获得了非常理想的和否则无法获得的热力学更稳定的顶端双衍生物。(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2007)
  • Method for Producing Substituted Diamantanes
    申请人:Schreiner Peter R.
    公开号:US20100036153A1
    公开(公告)日:2010-02-11
    The invention at hand provides at least dinitroxylated diamantanes. In addition, it provides methods for producing substituted diamantanes with high yields and selectivity. According to the invention, dinitroxylated diamantanes are suitable for being reacted with nucleophiles to form the corresponding disubstituted diamantanes. Surprisingly, it was discovered that at least dinitroxylated or hydroxylated diamantanes are rearranged in the presence of a strong acid, creating at least 4,9-nitroxylated or hydroxylated diamantanes. On the basis of this, 4,9-substituted diamantanes are able to be produced in a targeted manner by reaction with further nucleophiles. Thus, the invention at hand provides the following methods according to the present invention for producing at least disubstituted diamantanes: a) at least dinitroxylation, followed by the substitution of all nitroxy groups by a nucleophile or b) at least dinitroxylation, subsequent rearrangement in the presence of a strong acid, after realised rearrangement all nitroxy groups are replaced by a nucleophile or c) at least dinitroxylation, subsequent reaction with water (as nucleophile), rearrangement of the at least dihydroxylated compound in the presence of a strong acid, after realised rearrangement all hydroxy groups are replaced by another nucleophile.
    该发明提供至少二硝基化二莽烷。此外,它提供了一种高产率和选择性生产取代二莽烷的方法。根据该发明,二硝基化的二莽烷适合与亲核试剂反应,形成相应的二取代二莽烷。令人惊讶的是,在强酸存在的情况下发现,至少二硝基化或羟基化的二莽烷会重排,形成至少4,9-硝基化或羟基化的二莽烷。基于此,通过与进一步的亲核试剂反应,可以有针对性地生产4,9-取代的二莽烷。因此,该发明提供了以下根据本发明的方法,用于生产至少二取代的二莽烷:a) 至少二硝基化,然后用亲核试剂替换所有硝基团或b) 至少二硝基化,后在强酸存在下重排,重排后用亲核试剂替换所有硝基团或c) 至少二硝基化,后与(作为亲核试剂)反应,在强酸存在下重排,重排后用另一亲核试剂替换所有羟基。
  • Diamondoid derivatives possessing therapeutic activity in the treatment of neurologic disorders
    申请人:Liu Shenggao
    公开号:US20080009546A1
    公开(公告)日:2008-01-10
    This invention relates to diamondoid derivatives which exhibit therapeutic activity. Specifically, the diamondoid derivatives herein exhibit therapeutic effects in the treatment of neurologic disorders. Also provided are methods of treatment, prevention and inhibition of neurologic disorders in a subject in need.
    本发明涉及表现出治疗活性的金刚烷生物。具体而言,本发明中的金刚烷生物在治疗神经疾病方面表现出治疗效果。同时提供了治疗、预防和抑制需要治疗神经疾病的受试者的方法。
  • Vodicka, Ludek; Janku, Josef; Burkhard, Jiri, Collection of Czechoslovak Chemical Communications, 1983, vol. 48, # 4, p. 1162 - 1172
    作者:Vodicka, Ludek、Janku, Josef、Burkhard, Jiri
    DOI:——
    日期:——
  • VODICKA, L.;JANKU, J.;BURKHARD, J., COLLECT. CZECH. CHEM. COMMUN., 1983, 48, N 4, 1162-1172
    作者:VODICKA, L.、JANKU, J.、BURKHARD, J.
    DOI:——
    日期:——
查看更多